Delivery Order SPE2DB24D2216-SPE2DB25FGPWG
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $7.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,969.43 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 158 mg on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jatenzo is a testosterone replacement therapy medication used in the treatment of hypogonadism,...
- The Defense Logistics Agency awarded a delivery order valued at $2,263.74 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jatenzo is a testosterone replacement therapy medication used to treat hypogonadism in adult males,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Jatenzo 237 mg capsules (120 count) valued at $1,640.34. This firm fixed-price delivery order, which is scheduled for completion by August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $1,131.87 to AmerisourceBergen Drug Corp for JATENZO 237 mg capsules (120 count) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. JATENZO is a testosterone replacement therapy medication used to treat hypogonadism in male...
- The Defense Logistics Agency awarded a delivery order valued at $1,131.87 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Jatenzo is a testosterone replacement therapy indicated for hypogonadism treatment, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $2,137.63 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg, a testosterone replacement therapy medication. This non-set-aside, competitively awarded contract was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and operates under a firm fixed price arrangement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $3,988.39 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,273.70 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg, a testosterone replacement therapy medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of August 20, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jatenzo 237 mg capsules (120 count) under a firm fixed-price contract with a ceiling value of $1,131.87. The contract, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,877.30 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location....